Putnam, an Inizio Advisory Company, is a premier strategic consulting partner for pharmaceutical and life science companies serving a range of biopharmaceutical, diagnostics, medtech, and private equity/venture capital clients. For more than 30 years, we have provided high-impact strategic advice and analytical services, helping our clients solve their most complex challenges across the patient journey and franchise lifecycle to bring preventions and treatments to those that need them. We offer an unparalleled depth and breadth of advisory service expertise combined with scientific and technical capabilities across strategic and therapeutic areas. We listen to client needs, help shape hypotheses, analyze data, and advise on the strategy of life-changing therapies, empowering better decisions to create long-term value for patients.
We pride ourselves on a team-based approach that is client focused and impact oriented. We serve many of the industry leaders, including the top 20 global biopharmaceutical companies. Most of our studies combine sophisticated quantitative analytics with significant qualitative fact-finding and synthesis to inform strategic decision-making. Our diverse casework spans portfolio prioritization, development pathway and resource optimization, market assessment, product pricing and launch strategies, market segment growth strategies, sales and marketing strategies, franchise development and patent expiration strategies.